Edition:
India

Profile: Celon Pharma SA (CLNP.WA)

CLNP.WA on Warsaw Stock Exchange

43.25PLN
18 Oct 2019
Change (% chg)

-0.95zł (-2.15%)
Prev Close
44.20zł
Open
44.25zł
Day's High
44.65zł
Day's Low
43.15zł
Volume
4,423
Avg. Vol
10,264
52-wk High
51.10zł
52-wk Low
28.25zł

Celon Pharma SA is a Poland-based company primarily engaged in the pharmaceuticals manufacture. The Company focuses on research, development and production of generic drugs for cancer, neurological diseases, diabetes and other metabolic disorders treatment, among others. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir and Valzek, as well as inhalation powder, such as Salmex. The Company's research center develops pharmaceuticals within a number of therapeutic areas, including oncology, neurology, as well as inflammatory and metabolic diseases. The Company is a subsidiary of Glatton sp z o o.

Company Address

Celon Pharma SA

ul. Ogrodowa 2A, Kielpin
    05-092
P: +4822.7515933
F: +4822.7514458

Company Web Links